Every story in this section, newest first — page 245 of 373.
Waterdrop (NYSE:WDH), a leading technology-driven platform dedicated to insurance and healthcare services, reported a robust financial performance for the fourth quarter and full year ended December 31, 2025.
Viomi Technology (NASDAQ:VIOT), a leading provider of internet-connected home appliances, reported its unaudited financial results for the second half and full year ended December 31, 2025, on Wednesday.
Zhihu (NYSE:ZH), the operator of China’s largest online Q&A community, reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on March 25, 2026.
SpaceX is preparing to file a prospectus for an initial public offering as soon as this week, according to reports from The Information, signaling what could become the largest stock market debut in history.
So-Young International (NASDAQ:SY), a life services platform in China, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on March 25, 2026.
DouYu International Holdings (NASDAQ:DOYU) released its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on March 25, 2026, marking a year of operational stabilization and improved bottom-line performance.
AIxCrypto Holdings (NASDAQ:AIXC) detailed its year-end financial position on Wednesday, formalizing the financial impact of its wholesale strategic pivot from clinical-stage biotechnology to artificial intelligence and blockchain infrastructure.
Flex LNG (NYSE:FLNG) has secured a new time charter agreement for its liquefied natural gas carrier, the Flex Aurora, ensuring immediate employment for the vessel following its redelivery in early March 2026.
BioAge Labs (NASDAQ:BIOA) today reported its financial results for the full year ended December 31, 2025, marking a pivotal transition from early-stage discovery to a high-conviction clinical platform.
Compass Pathways (NASDAQ:CMPS) today reported its financial results for the fourth quarter and full year ended December 31, 2025, revealing a disciplined fiscal year characterized by strategic cost management and a significantly extended capital runway.
Tech titan Oracle has launched its AI Customer Excellence Centre in Sydney.
Circle Internet Group (NASDAQ:CRCL) experienced its most volatile trading session on record Tuesday, with shares plunging as much as 20% following leaked reports regarding the latest draft of the Digital Asset Market Clarity Act.
Apple (NASDAQ:AAPL) today announced a significant expansion of its advertising ecosystem, confirming that paid search ads will debut on Apple Maps in the United States and Canada this summer.
Energy Focus (NASDAQ:EFOI) today reported its financial results for the fourth quarter and full year ended December 31, 2025, reflecting a period of narrowed losses and continued focus on high-specification lighting solutions.
Trian Fund Management and General Catalyst Group Management today announced a definitive amendment to their merger agreement with Janus Henderson Group (NYSE:JHG), raising the acquisition price to $52 per share in cash.
Sanara MedTech (NASDAQ:SMTI) today announced its financial results for the fourth quarter and full year ended December 31, 2025, marking the first time the company has surpassed the $100 million annual revenue threshold.
Perma-Fix Environmental Services (NASDAQ:PESI) today reported financial results for the full year ended December 31, 2025, detailing a year of strategic capacity expansion and a significant buildup in high-margin service demand.
Neurogene (NASDAQ:NGNE) today reported financial results for the fourth quarter and full year ended December 31, 2025, delivering a "beat" against Wall Street’s bottom-line expectations.
LENZ Therapeutics (NASDAQ:LENZ) today reported its financial results for the fourth quarter and full year ended December 31, 2025, providing the first comprehensive look at the commercial performance of VIZZ® (aceclidine 1.44%).
Heidmar Maritime Holdings (NASDAQ:HMR) today reported its financial results for the fourth quarter and full year ended December 31, 2025, highlighting a period of rapid institutional scaling.
Ocugen (NASDAQ:OCGN) today announced positive 12-month results from its Phase 2 ArMaDa clinical trial evaluating OCU410 (AAV-hRORA), a modifier gene therapy for the treatment of Geographic Atrophy (GA) secondary to dry Age-Related Macular Degeneration (dAMD).
NRx Pharmaceuticals (NASDAQ:NRXP) today reported its financial results and operational milestones for the full year ended December 31, 2025, highlighting a successful restructuring of its balance sheet and the transition into a revenue-generating entity.
Concentrix (NASDAQ:CNXC) today reported its financial results for the fiscal first quarter ended February 28, 2026, demonstrating steady top-line expansion and a continued commitment to shareholder returns.
Core & Main (NYSE:CNM) today reported financial results for the fourth quarter and fiscal year ended February 1, 2026, showcasing a year of disciplined margin management and robust cash generation.
